Total Valuation
Quest Diagnostics has a market cap or net worth of $520.49B. The enterprise value is $31.99B.
Market Cap$520.49B
Enterprise Value$31.99B
Share Statistics
Quest Diagnostics has 110,019,070 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding110,019,070
Owned by Insiders0.45%
Owned by Institutions3.40%
Financial Efficiency
Quest Diagnostics’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 8.43%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)8.43%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee193.60K
Profits Per Employee18.35K
Employee Count57,000
Asset Turnover0.68
Inventory Turnover39.75
Valuation Ratios
The current PE Ratio of Quest Diagnostics is 24.7. Quest Diagnostics’s PEG ratio is 1.43.
PE Ratio24.7
PS Ratio1.75
PB Ratio2.69
Price to FCF14.17
Price to Operating Cash Flow14.20
PEG Ratio1.43
Income Statement
In the last 12 months, Quest Diagnostics had revenue of 11.04B and earned 992.00M in profits. Earnings per share was 8.87.
Revenue11.04B
Gross Profit3.52B
Operating Income1.60B
Pretax Income1.36B
Net Income992.00M
EBITDA2.19B
Earnings Per Share (EPS)8.87
Cash Flow
In the last 12 months, operating cash flow was 1.95B and capital expenditures -576.00M, giving a free cash flow of 1.38B billion.
Operating Cash Flow1.95B
Free Cash Flow1.38B
Free Cash Flow per Share12.50
Dividends & Yields
Quest Diagnostics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.04
52-Week Price Change32.33%
50-Day Moving Average4.06K
200-Day Moving Average3.63K
Relative Strength Index (RSI)99.37
Average Volume (3m)0.00
Important Dates
Quest Diagnostics upcoming earnings date is Feb 4, 2027, Before Open (Confirmed).
Last Earnings DateOct 22, 2026
Next Earnings DateFeb 4, 2027
Ex-Dividend Date―
Financial Position
Quest Diagnostics as a current ratio of 1.04, with Debt / Equity ratio of 82.35%
Current Ratio1.04
Quick Ratio0.96
Debt to Market Cap0.33
Net Debt to EBITDA2.96
Interest Coverage Ratio5.79
Taxes
In the past 12 months, Quest Diagnostics has paid 314.00M in taxes.
Income Tax314.00M
Effective Tax Rate0.23
Enterprise Valuation
Quest Diagnostics EV to EBITDA ratio is 11.74, with an EV/FCF ratio of 18.96.
EV to Sales2.33
EV to EBITDA11.74
EV to Free Cash Flow18.96
EV to Operating Cash Flow13.66
Balance Sheet
Quest Diagnostics has $797.00M in cash and marketable securities with $6.29B in debt, giving a net cash position of -$5.49B billion.
Cash & Marketable Securities$797.00M
Total Debt$6.29B
Net Cash-$5.49B
Net Cash Per Share-$49.88
Tangible Book Value Per Share-$29.68
Margins
Gross margin is 33.15%, with operating margin of 14.53%, and net profit margin of 8.99%.
Gross Margin33.15%
Operating Margin14.53%
Pretax Margin12.32%
Net Profit Margin8.99%
EBITDA Margin19.88%
EBIT Margin14.72%
Analyst Forecast
The average price target for Quest Diagnostics is $4,901.27, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$4,901.27
Price Target Upside19.48% Upside
Analyst ConsensusModerate Buy
Analyst Count7
Revenue Growth Forecast-2.14%
EPS Growth Forecast5.67%